{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T08:04:24Z","timestamp":1782979464717,"version":"3.54.5"},"reference-count":19,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T00:00:00Z","timestamp":1578873600000},"content-version":"vor","delay-in-days":2356,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100006506","name":"Depomed, Inc.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100006506","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpsmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pain and Symptom Management"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.jpainsymman.2012.07.011","type":"journal-article","created":{"date-parts":[[2012,11,10]],"date-time":"2012-11-10T20:45:33Z","timestamp":1352580333000},"page":"219-228","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Once-Daily Gastroretentive Gabapentin for Postherpetic Neuralgia: Integrated Efficacy, Time to Onset of Pain Relief and Safety Analyses of Data From Two Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Studies"],"prefix":"10.1016","volume":"46","author":[{"given":"Richard L.","family":"Rauck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon A.","family":"Irving","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark S.","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geertrui F.","family":"Vanhove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Sweeney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpainsymman.2012.07.011_bib1","first-page":"1","article-title":"Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"57","author":"Harpaz","year":"2008","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.jpainsymman.2012.07.011_bib2","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.4065\/82.11.1341","article-title":"A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction","volume":"82","author":"Yawn","year":"2007","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jpainsymman.2012.07.011_bib3","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1056\/NEJMcp013211","article-title":"Clinical practice. Herpes zoster","volume":"347","author":"Gnann","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jpainsymman.2012.07.011_bib4","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1001\/jama.280.21.1837","article-title":"Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial","volume":"280","author":"Rowbotham","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.jpainsymman.2012.07.011_bib5","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0304-3959(01)00407-9","article-title":"Gabapentin in postherpetic neuralgia: a randomised, double blind, placebo controlled study","volume":"94","author":"Rice","year":"2001","journal-title":"Pain"},{"key":"10.1016\/j.jpainsymman.2012.07.011_bib6","doi-asserted-by":"crossref","first-page":"759","DOI":"10.2337\/diacare.29.04.06.dc05-1967","article-title":"Efficacy, tolerability, and safety of a novel once-daily extended-release metformin in patients with type 2 diabetes","volume":"29","author":"Schwartz","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jpainsymman.2012.07.011_bib7","series-title":"GRALISE\u00ae (gabapentin) prescribing information","year":"2012"},{"key":"10.1016\/j.jpainsymman.2012.07.011_bib8","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1023\/A:1018951214146","article-title":"A\u00a0saturable transport mechanism in the intestinal absorption of gabapentin is the underlying cause of the lack of proportionality between increasing dose and drug levels in plasma","volume":"10","author":"Stewart","year":"1993","journal-title":"Pharm Res"},{"key":"10.1016\/j.jpainsymman.2012.07.011_bib9","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.clinthera.2008.05.008","volume":"30","author":"Gordi","year":"2008","journal-title":"Clin Ther"},{"key":"10.1016\/j.jpainsymman.2012.07.011_bib10","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1177\/0091270010368411","article-title":"Pharmacokinetics of gabapentin in a novel gastric-retentive extended-release formulation: comparison with an immediate release formulation and effect of dose escalation and food","volume":"51","author":"Chen","year":"2011","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.jpainsymman.2012.07.011_bib11","doi-asserted-by":"crossref","first-page":"765","DOI":"10.2165\/11539520-000000000-00000","article-title":"Gabapentin extended-release tablets for the treatment of patients with postherpetic neuralgia: a randomized, double-blind, placebo-controlled, multicentre study","volume":"30","author":"Wallace","year":"2010","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.jpainsymman.2012.07.011_bib12","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/AJP.0b013e318258993e","article-title":"Gastroretentive gabapentin (G-GR) formulation reduces intensity of pain associated with postherpetic neuralgia (PHN)","volume":"29","author":"Sang","year":"2013","journal-title":"Clin J Pain"},{"key":"10.1016\/j.jpainsymman.2012.07.011_bib13","series-title":"ECDEU assessment manual for psychopharmacology (DHEW Publication No. ADM 76-338)","author":"Guy","year":"1976"},{"key":"10.1016\/j.jpainsymman.2012.07.011_bib14","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/MJT.0b013e3181d5e4f3","article-title":"Time to onset of neuropathic pain reduction: a retrospective analysis of data from nine controlled trials of pregabalin for painful diabetic peripheral neuropathy and postherpetic neuralgia","volume":"17","author":"Sharma","year":"2010","journal-title":"Am J Ther"},{"key":"10.1016\/j.jpainsymman.2012.07.011_bib15","first-page":"1006","article-title":"Pregabalin for postherpetic neuralgia: placebo-controlled trial of fixed and flexible dosing regimens on allodynia and time to onset of pain relief","volume":"9","author":"Stacey","year":"2008","journal-title":"J\u00a0Pain"},{"key":"10.1016\/j.jpainsymman.2012.07.011_bib16","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1212\/01.WNL.0000055433.55136.55","article-title":"Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial","volume":"60","author":"Dworkin","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.jpainsymman.2012.07.011_bib17","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00482-005-0449-0","volume":"20","author":"Freynhagen","year":"2006","journal-title":"Schmerz"},{"key":"10.1016\/j.jpainsymman.2012.07.011_bib18","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0304-3959(01)00349-9","article-title":"Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale","volume":"94","author":"Farrar","year":"2001","journal-title":"Pain"},{"key":"10.1016\/j.jpainsymman.2012.07.011_bib19","first-page":"CD007938","article-title":"Gabapentin for chronic neuropathic pain and fibromyalgia in adults","volume":"3","author":"Moore","year":"2011","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Journal of Pain and Symptom Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392412003971?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392412003971?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:10:22Z","timestamp":1760130622000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0885392412003971"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S0885392412003971"],"URL":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2012.07.011","relation":{},"ISSN":["0885-3924"],"issn-type":[{"value":"0885-3924","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Once-Daily Gastroretentive Gabapentin for Postherpetic Neuralgia: Integrated Efficacy, Time to Onset of Pain Relief and Safety Analyses of Data From Two Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Studies","name":"articletitle","label":"Article Title"},{"value":"Journal of Pain and Symptom Management","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2012.07.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 U.S. Cancer Pain Relief Committee. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}